INTERACTIONS BETWEEN DOPAMINE AND 5-HT3 RECEPTORS SUGGEST NEW TREATMENTS FOR PSYCHOSIS AND DRUG-ADDICTION

被引:82
作者
TRICKLEBANK, MD
机构
关键词
D O I
10.1016/0165-6147(89)90157-0
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:127 / 129
页数:3
相关论文
共 20 条
[1]   IDENTIFICATION OF 5-HT3 RECOGNITION SITES IN HUMAN-BRAIN TISSUE USING (H-3) ZACOPRIDE [J].
BARNES, NM ;
COSTALL, B ;
IRONSIDE, JW ;
NAYLOR, RJ .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1988, 40 (09) :668-668
[2]   ACTIVATION OF A 5-HT3 RECEPTOR RELEASES DOPAMINE FROM RAT STRIATAL SLICE [J].
BLANDINA, P ;
GOLDFARB, J ;
GREEN, JP .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1988, 155 (03) :349-350
[3]   5-HT3 RECEPTOR ANTAGONISTS BLOCK MORPHINE-INDUCED AND NICOTINE-INDUCED PLACE-PREFERENCE CONDITIONING [J].
CARBONI, E ;
ACQUAS, E ;
LEONE, P ;
PEREZZANI, L ;
DICHIARA, G .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1988, 151 (01) :159-160
[4]  
COSTALL B, 1987, British Journal of Pharmacology, V90, p89P
[5]   EFFECTS OF THE 5-HT3 RECEPTOR ANTAGONIST, GR38032F, ON RAISED DOPAMINERGIC ACTIVITY IN THE MESOLIMBIC SYSTEM OF THE RAT AND MARMOSET BRAIN [J].
COSTALL, B ;
DOMENEY, AM ;
NAYLOR, RJ ;
TYERS, MB .
BRITISH JOURNAL OF PHARMACOLOGY, 1987, 92 (04) :881-894
[6]   NEUROANATOMICAL SITES OF ACTION OF 5-HT3 RECEPTOR AGONIST AND ANTAGONISTS FOR ALTERATION OF AVERSIVE BEHAVIOR IN THE MOUSE [J].
COSTALL, B ;
KELLY, ME ;
NAYLOR, RJ ;
ONAIVI, ES ;
TYERS, MB .
BRITISH JOURNAL OF PHARMACOLOGY, 1989, 96 (02) :325-332
[7]  
COSTALL B, 1988, BRIT J PHARMACOL, V94, pP390
[8]  
COSTALL B, IN PRESS BR J PHARM
[9]  
DICHIARA G, 1988, P NATL ACAD SCI USA, V85, P5274
[10]   THE BEHAVIORAL-EFFECTS OF A NOVEL SUBSTANCE-P ANALOG FOLLOWING INFUSION INTO THE VENTRAL TEGMENTAL AREA OR SUBSTANTIA NIGRA OF RAT-BRAIN [J].
EISON, AS ;
EISON, MS ;
IVERSEN, SD .
BRAIN RESEARCH, 1982, 238 (01) :137-152